Aggregator

• Agreement’s adoption follows three years of intensive negotiation launched due to gaps and inequities identified in national and global COVID-19 response.
• Agreement boosts global collaboration to ensure stronger, more equitable response to future pandemics.
• Next steps include negotiations on Pathogen Access and Benefits Sharing system.

Member States of the World Health Organization (WHO) today formally adopted by consensus the world's first Pandemic Agreement. The landmark decision by the 78th World Health Assembly culminates more than three years of intensive negotiations launched by governments in response to the devastating impacts of the COVID-19 pandemic, and driven by the goal of making the world safer from – and more equitable in response to – future pandemics.

“The world is safer today thanks to the leadership, collaboration and commitment of our Member States to adopt the historic WHO Pandemic Agreement,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “The Agreement is a victory for public health, science and multilateral action. It will ensure we, collectively, can better protect the world from future pandemic threats. It is also a recognition by the international community that our citizens, societies and economies must not be left vulnerable to again suffer losses like those endured during COVID-19.”  

Governments adopted the WHO Pandemic Agreement today in a plenary session of the World Health Assembly, WHO’s peak decision-making body. The adoption followed yesterday’s approval of the Agreement by vote (124 in favour, 0 objections, 11 abstentions) in Committee by Member State delegations.

“Starting during the height of the COVID-19 pandemic, governments from all corners of the world acted with great purpose, dedication and urgency, and in doing so exercising their national sovereignty, to negotiate the historic WHO Pandemic Agreement that has been adopted today,” said Dr Teodoro Herbosa, Secretary of the Philippines Department of Health, and President of this year’s World Health Assembly, who presided over the Agreement’s adoption. “Now that the Agreement has been brought to life, we must all act with the same urgency to implement its critical elements, including systems to ensure equitable access to life-saving pandemic-related health products. As COVID was a once-in-a-lifetime emergency, the WHO Pandemic Agreement offers a once-in-a-lifetime opportunity to build on lessons learned from that crisis and ensure people worldwide are better protected if a future pandemic emerges.”

The WHO Pandemic Agreement sets out the principles, approaches and tools for better international coordination across a range of areas, in order to strengthen the global health architecture for pandemic prevention, preparedness and response. This includes through the equitable and timely access to vaccines, therapeutics and diagnostics.

Regarding national sovereignty, the Agreement states that: “Nothing in the WHO Pandemic Agreement shall be interpreted as providing the Secretariat of the World Health Organization, including the Director-General of the World Health Organization, any authority to direct, order, alter or otherwise prescribe the national and/or domestic law, as appropriate, or policies of any Party, or to mandate or otherwise impose any requirements that Parties take specific actions, such as ban or accept travellers, impose vaccination mandates or therapeutic or diagnostic measures or implement lockdowns.”

Notes for editors

The resolution on the WHO Pandemic Agreement adopted by the World Health Assembly sets out steps to prepare for the accord’s implementation. It includes launching a process to draft and negotiate a Pathogen Access and Benefit Sharing system (PABS) through an Intergovernmental Working Group (IGWG). The result of this process will be considered at next year’s World Health Assembly.

Once the Assembly adopts the PABS annex, the WHO Pandemic Agreement will then be open for signature and consideration of ratification, including by national legislative bodies. After 60 ratifications, the Agreement will enter into force.

In addition, Member States also directed the IGWG to initiate steps to enable setting up of the Coordinating Financial Mechanism for pandemic prevention, preparedness and response, and the Global Supply Chain and Logistics Network (GSCL) to “enhance, facilitate, and work to remove barriers and ensure equitable, timely, rapid, safe, and affordable access to pandemic-related health products for countries in need during public health emergencies of international concern, including pandemic emergencies, and for prevention of such emergencies.”

According to the Agreement, pharmaceutical manufacturers participating in the PABS system will play a key role in equitable and timely access to pandemic-related health products by making available to WHO “rapid access targeting 20% of their real time production of safe, quality and effective vaccines, therapeutics, and diagnostics for the pathogen causing the pandemic emergency.”  The distribution of these products to countries will be carried out on the basis of public health risk and need, with particular attention to the needs of developing countries.

The WHO Pandemic Agreement is the second international legal agreement negotiated under Article 19 of the WHO Constitution, the first being the WHO Framework Convention on Tobacco Control, which was adopted in 2003 and entered into force in 2005.

World Health Organization Member States, meeting today in Committee A of the World Health Assembly, approved a resolution that calls for the adoption of an historic global compact to make the world safer from future pandemics. The WHO Pandemic Agreement will next be considered for final adoption by the Assembly on Tuesday during the plenary session.

Monday’s approval of the Pandemic Agreement resolution follows a more than three-year process, launched by governments during the COVID-19 pandemic, to negotiate the world’s first such accord to address the gaps and inequities in preventing, preparing for and responding to pandemics. This watershed agreement was adopted under Article 19 of the WHO Constitution. It aims to foster stronger collaboration and cooperation among countries, international organizations like WHO, civil society, the private sector and other stakeholders to prevent pandemics occurring in the first place, and to better respond in the event of a future pandemic crisis.

“Governments from all over the world are making their countries, and our interconnected global community, more equitable, healthier and safer from the threats posed by pathogens and viruses of pandemic potential,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. “I congratulate WHO‘s Member States for resolving to come together in the aftermath of COVID-19 to better protect the world from future pandemics. Their work to develop this global accord will ensure countries work better, faster and more equitably together to prevent and respond to the next pandemic threat.”

The Pandemic Agreement and the resolution calling for its adoption will be taken up by the full plenary of the World Health Assembly on Tuesday, 20 May. Immediately after, there will be a High-Level segment featuring statements from Heads of States of multiple countries.

“The WHO Pandemic Agreement is a demonstration of the shared desire by all people to be better prepared to prevent and respond to the next pandemic, with a commitment to the principles of respect for human dignity, equity, solidarity and sovereignty, and basing public health decisions to control pandemics on the best available science and evidence,” said the Honorable Dr Esperance Luvindao, Minister of Health and Social Services of Namibia, and Chair of the Committee A meeting that adopted today’s resolution. “The costs that COVID inflicted on lives, livelihoods and economies were great and many, and we – as sovereign states – have resolved to join hands, as one world together, so we can protect our children, elders, frontline health workers and all others from the next pandemic. It is our duty and responsibility to humanity.”

The resolution sets out several steps for taking the world forward and preparing for the Pandemic Agreement’s implementation. It includes the launch of a process to draft and negotiate an annex to the Agreement that would establish a Pathogen Access and Benefit Sharing system (PABS) through an Intergovernmental Working Group (IGWG). The result of this process will be considered at next year’s World Health Assembly. Once the Assembly adopts the PABS annex, the Pandemic Agreement will then be open for signature and consideration of ratification, including by national legislative bodies. After 60 ratifications, the Agreement will enter into force.

In addition, Member States also directed the IGWG to initiate steps to enable setting up of the Coordinating Financial Mechanism for pandemic prevention, preparedness and response, and the Global Supply Chain and Logistics Network (GSCL) to “enhance, facilitate, and work to remove barriers and ensure equitable, timely, rapid, safe, and affordable access to pandemic-related health products for countries in need during public health emergencies of international concern, including pandemic emergencies, and for prevention of such emergencies.”

According to the Agreement, pharmaceutical manufacturers participating in the PABS system will play a key role in equitable and timely access to pandemic-related health products by making available to WHO “rapid access targeting 20% of their real time production of safe, quality and effective vaccines, therapeutics, and diagnostics for the pathogen causing the pandemic emergency.”  The distribution of these products to countries will be carried out on the basis of public health risk and need, with particular attention to the needs of developing countries and those supported through the GSCL.

The Pandemic Agreement aligns with the International Health Regulations, amendments to which were adopted by governments at last year’s World Health Assembly to bolster international rules to better detect, prevent and respond to outbreaks.

Dr Tedros thanked the Bureau of the Intergovernmental Negotiating Body (INB) that coordinated and facilitated the process to draft and negotiate the Pandemic Agreement. The WHO Director-General also praised the tireless work and excellence of the WHO Secretariat team that supported the Bureau and Member States, led by Dr Michael Ryan and Dr Jaouad Mahjour.

“An immensely talented, experienced and driven WHO team was assembled to support the vision of governments to develop this historic Pandemic Agreement,” Dr Tedros said. “This group of individuals, representing so many countries and regions of the world, deserve enormous credit and thanks from the international community for what they have done to help make the world safer for future generations.”

The INB was established in December 2021, at a special session of the World Health Assembly. WHO Member States were tasked to develop a convention, agreement or other international instrument under the WHO Constitution to strengthen pandemic preparedness, prevention and response. Members of the INB Bureau that guided the process were Co-Chairs Ms Precious Matsoso (South Africa) and Ambassador Anne-Claire Amprou (France), and Vice-Chairs Ambassador Tovar da Silva Nunes (Brazil), Ambassador Amr Ramadan (Egypt), Dr Viroj Tangcharoensathien (Thailand); and Ms Fleur Davies (Australia). Past members included former Co-Chair, Mr Roland Driece (the Netherlands), and former Vice-Chairs Ambassador Honsei Kozo (Japan), Mr Kazuho Taguchi (Japan), and Mr Ahmed Soliman (Egypt).

In a landmark public health achievement, Papua New Guinea (PNG) has been validated by the World Health Organization (WHO) for eliminating trachoma as a public health problem. Trachoma, a neglected tropical disease (NTD) and the world’s leading infectious cause of blindness, no longer poses a public health threat in the country.

"I congratulate the government and people of Papua New Guinea on this incredible achievement, said Dr Tedros Adhanom Ghebreyesus," WHO Director-General. "This success demonstrates what can be achieved when science and sustained partnerships come together to serve the health and dignity of communities."

Official recognition was made during the 78th World Health Assembly held in Geneva, Switzerland, following a comprehensive review of PNG's elimination dossier.

Trachoma is caused by the bacterium Chlamydia trachomatis and spreads through personal contact, flies that have been in contact with eye or nose discharge and contact with infected surfaces. Repeated infections can lead to scarring, in-turning of the eyelids, and ultimately irreversible blindness. Globally, the disease remains endemic in many vulnerable communities where access to clean water and sanitation is limited.

"Papua New Guinea's achievement is an example of medical science in action," said Dr Saia Ma'u Piukala, WHO Regional Director for the Western Pacific. “It reflects a deep understanding of local epidemiology and a commitment to using the right interventions for the right reasons. We commend the National Department of Health, health workers, researchers, and partners for their persistent efforts."

In PNG, population-based surveys conducted in 2015 found signs of active trachoma in children but very low levels of Chlamydia trachomatis, as well as negligible levels of trachomatous trichiasis – the advanced stage of the disease that causes blindness. A follow-up ancillary survey in 2020 further confirmed that affected children were not progressing to more severe disease. This epidemiological pattern, shared with other Melanesian countries, provided the foundation for PNG’s successful claim to have eliminated trachoma as a public health problem.

Unlike many other countries where trachoma elimination has required surgery campaigns, antibiotic mass drug administration and targeted improvements in access to water, sanitation and hygiene, PNG’s success was driven by robust disease surveillance. The country’s National Department of Health, with the support from partners, oversaw a series of rapid assessments, prevalence surveys, and community-level investigations. These efforts confirmed that community-wide interventions for trachoma were not warranted.

PNG's trachoma elimination programme received technical and financial support from WHO, the Australian Department of Foreign Affairs and Trade, the Fred Hollows Foundation, the Brien Holden Vision Institute, Sightsavers, PNG Eye Care, and several other organizations. The programme also benefited from scientific collaborations with the Papua New Guinea Institute of Medical Research, the Global Trachoma Mapping Project, Collaborative Vision, Tropical Data and the London School of Hygiene & Tropical Medicine, among many others.

Since 2016, 13 countries in the Western Pacific Region have been validated by WHO for eliminating at least one NTD. Trachoma elimination is part of broader progress on NTDs in PNG and the Western Pacific Region.

Trachoma is the first neglected tropical disease eliminated in PNG. Following this successful validation, globally, 56 countries have eliminated at least one NTD, including 22 others that have eliminated trachoma as a public health problem. PNG joining these groups enhances our collective momentum toward the targets of the NTD road map 2021–2030.

WHO continues to support countries in their efforts to eliminate trachoma and other NTDs, ensuring healthier lives for all, particularly the most disadvantaged.

The World Health Organization (WHO) has recognized four countries—the Republic of Austria, the Kingdom of Norway, the Sultanate of Oman and the Republic of Singapore—for their exemplary efforts in eliminating industrially produced trans fats from their food supplies. These countries, which were validated earlier this year, have implemented best-practice policies alongside effective monitoring and enforcement mechanisms to promote public health. This brings the total number of countries validated to nine, including Denmark, Lithuania, Poland, Saudi Arabia and Thailand, which were recognized in 2024.

The WHO validation certificates for 2025 were officially presented by WHO Director-General Dr Tedros Adhanom Ghebreyesus during the Seventy-eighth World Health Assembly. “Eliminating industrially produced trans fats is one of the most cost-effective strategies to reduce the global burden of cardiovascular diseases. Trans fats are a major contributor to preventable deaths each year, particularly due to their impact on heart health,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “These countries are not only protecting the health of their populations, but also setting an exemplary standard for other countries to follow.”

This recognition marks another significant milestone in the global effort to eliminate trans fats, reflecting not only policy commitments but also the concrete actions being taken to remove trans fat from the food supply.

Trans fat clogs arteries, increasing the risk of heart attacks and coronary heart disease – responsible for over 278 000 deaths each year globally. Trans fat, or trans-fatty acids (TFA), are unsaturated fatty acids that come from either artificial (industrial) or natural sources. Industrially produced trans fats are often found in many baked goods such as biscuits, pies and fried foods, as well as margarine, vegetable shortening, Vanaspati ghee, among many others. Both industrially produced and naturally occurring trans fats are equally harmful.

“Recognizing the incredible harm caused by industrially produced trans fats, we became the second country to introduce measures to eliminate it. An EU-wide regulation is now in place, and Austria acknowledges its pioneering role in this important development. Bold, evidence-based policies can deliver real public health impact, and we are proud to be among the countries leading this global effort,” said Korinna Schumann, Minister of Labour, Social Affairs, Health, Care and Consumer Protection, Austria.

Seven years ago, WHO called for the global elimination of industrially produced trans fats. At that time, only 11 countries covering 6% of the global population had best-practice trans-fat elimination policies in effect. Today, nearly 60 countries have best-practice policies in effect, covering 46% of the global population.

“Eliminating industrially produced trans fats marks a significant milestone in our commitment to protecting our population’s health. We are proud to be among the 60 countries implementing this lifesaving policy, and especially honored to be recognized as one of the nine countries leading the way in eliminating this harmful ingredient,” said Dr Hilal bin Ali bin Hilal Alsabti, Minister of Health, Oman.

WHO recommends that governments implement best-practice trans fat elimination policies either by setting a mandatory limit of 2 grams of trans fat per 100 grams of total fat in all foods and/or by banning the production and use of partially hydrogenated oils (PHO) as an ingredient in food products. The WHO validation programme for trans fat elimination recognizes countries that have gone beyond introducing best practice policies by ensuring that rigorous monitoring and enforcement systems in place. Monitoring and enforcing compliance with policies is critical to maximizing and sustaining health benefits.

"Our efforts to implement robust best-practice trans fat elimination policies are showing clear, measurable results. Latest monitoring data confirm that it is possible to reduce trans fats intake in accordance with WHO’s recommendation on trans fat reduction”  said Jan Christian Vestre, Minister of Health and Care Services, Norway.

Replacing trans fats with healthier oils and fats is a low-cost intervention that yields high economic returns by improving population health, saving lives and reducing healthcare costs. Governments can eliminate the cause of 7% of cardiovascular disease globally with a low-cost investment aimed at reducing or eliminating trans fats from the food supply.

“Our journey towards eliminating industrially produced trans fats began over a decade ago. Today, we have made significant progress. This is a powerful testament to what can be achieved through applying a consistent public health policy, across countries and regions, and working collaboratively with the industries. We are proud to stand alongside other countries in building a healthier and safer food environment for all,” said Mr Ong Ye Kung, Minister for Health, Singapore.

WHO remains committed to supporting countries in their efforts and to recognizing their achievements. By working with national nutrition and food safety authorities, WHO can better support governments not only in developing and adopting trans fat elimination policies, but also in monitoring and enforcing them to ensure lasting impact.

The next application cycle for the TFA elimination validation programme is now open and countries are welcome to apply by 31 August 2025 to be considered for the third cycle.
 

Editor’s note 1

The World Health Organization has partnered with Resolve to Save Lives, a not-for-profit organization, to support the development and implementation of the REPLACE action package. Launched in 2018, the WHO’s REPLACE action package provides a strategic approach to eliminating industrially produced trans fat from national food supplies.

Editor’s note 2

On 23 May 2025, edits were made to the beginning of this news release as follows:

The World Health Organization (WHO) has recognized four countries – the Republic of Austria, the Kingdom of Norway, the Sultanate of Oman and the Republic of Singapore – for their exemplary efforts in eliminating industrially produced trans fats from their food supplies. These countries have implemented best-practice policies alongside effective monitoring and enforcement mechanisms to promote public health.

The WHO validation certificates were officially presented by WHO Director-General Dr Tedros Adhanom Ghebreyesus during the Seventy-eighth World Health Assembly.

was changed to:

The World Health Organization (WHO) has recognized four countries – the Republic of Austria, the Kingdom of Norway, the Sultanate of Oman and the Republic of Singapore – for their exemplary efforts in eliminating industrially produced trans fats from their food supplies. These countries, which were validated earlier this year, have implemented best-practice policies alongside effective monitoring and enforcement mechanisms to promote public health. This brings the total number of countries validated to nine, including Denmark, Lithuania, Poland, Saudi Arabia and Thailand, which were recognized in 2024.

The WHO validation certificates for 2025 were officially presented by WHO Director-General Dr Tedros Adhanom Ghebreyesus during the Seventy-eighth World Health Assembly. 

Philanthropic support plays a vital role in enabling countries to build stronger health systems and advance towards health equity. From vaccine equity and pandemic preparedness to primary health care, the contributions of philanthropic partners help drive progress across WHO’s key priorities.

The importance of philanthropic support was underscored by Dr Tedros Adhanom Ghebreyesus, WHO Director-General, in his recent remarks to the Philanthropy Asia Summit, held in Singapore on 5–7 May 2025. In his remarks, he expressed his appreciation to the Temasek Foundation and the Philanthropy Asia Alliance for organizing the Summit while highlighting the importance of philanthropy in strengthening global health, supporting country self-reliance, and partnering with WHO to address health challenges in an increasingly turbulent world.

At the Summit, Dr Tedros thanked His Excellency President Tharman and Singapore, for its leadership in global health and its support to WHO. Dr Tedros stated that Singapore and the Temasek Foundation were amongst the first to pledge support to WHO’s Investment Round.“We look forward to your continued leadership and partnership as we work together to realize WHO’s founding vision: the highest attainable standard of health – not as a luxury for some, but a right for all”, said Dr Tedros.

During the Investment Round, WHO has sought to expand its donor base, including by engaging strategically with philanthropic organizations. As Dr Tedros noted, partnerships with philanthropies help countries to strengthen essential health services and make sustainable progress towards universal health coverage.

Philanthropic actors play a vital role in improving global health outcomes, providing significant resources and expertise needed to build stronger and more accessible health-care systems. Investments made by philanthropic partners often complement and amplify the work of governments, international organizations and other stakeholders in the global health community.

Philanthropy can be particularly effective in supporting innovative or high-risk research that may not be funded though more traditional funding sources. Philanthropic actors are effective partners when it comes to raising awareness and advocating for policies to improve global health outcomes, address health disparities and promote health equity.

Looking ahead, philanthropic collaboration will remain central to achieving the goals outlined in WHO’s Fourteenth General Programme of Work. Developing strong partnerships with philanthropic actors allows WHO to leverage the strengths of a range of global health players to bring better health to people and maximize impact.

The Seventy-eighth session of the World Health Assembly (WHA78) will convene from 19 to 27 May 2025 in Geneva, Switzerland, under the theme “One World for Health”. 

The Health Assembly will bring together high-level country representatives and other stakeholders to address health challenges. This year’s gathering comes at a pivotal moment for global health, as Member States confront emerging threats and major shifts in the landscape for global health and international development.

This year’s theme underscores WHO’s enduring commitment to solidarity and equity, highlighting that even in unprecedented times, everyone, everywhere should have an equal chance to live a healthy life.  

A highly anticipated moment of the WHA78 will be the consideration of the Pandemic Agreement, a landmark proposal developed over three years of intense negotiations by the Intergovernmental Negotiating Body, composed of all WHO Member States. The adoption of the agreement is a once-in-a-generation opportunity to safeguard the world from a repeat of the suffering caused by the COVID-19 pandemic. The proposal will be the second ever presented for approval under Article 19 of the WHO Constitution, which gives Member States the authority to reach agreements on global health.

“This year’s World Health Assembly will be truly historic with countries, after 3 years of negotiations, considering for adoption the first global compact to better protect people from pandemics,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “The Pandemic Agreement can make the world safer by boosting collaboration among countries fairly in the preparedness, prevention and response to pandemics.” 

WHO’s sustainable financing is a key priority of the Health Assembly. Member States will consider a scheduled 20% increase in assessed contributions (membership fees), towards the next Programme Budget 2026–2027 (PB26-27). The PB26–27, also for approval by the Health Assembly, is the first full biennium under WHO’s Fourteenth General Programme of Work (GPW14), WHO’s strategy for global health for 2025–2028. The Programme Budget for 2026–2027 was under consultation by Member States, to prioritize activities and adjust the budget to the current financial realities, by reducing it by 22%, to US$ 4.267 billion, from the original proposed budget of US$ 5.3 billion. 

Reprioritization of WHO’s work, including cost-saving measures and budget adjustments, will also apply to the current year, 2025. The aim is to focus on WHO’s core work and increase efficiency. The reprioritization is a critical step to aligning WHO’s resources with the most urgent global health needs and getting health-related Sustainable Development Goals (SDGs) back on track. 

Sustainable financing was one of several transformation priorities put in place by the WHO Director-General to ensure a more efficient and impactful WHO when he first took office. On Tuesday, 20 May, there will be a high-level pledging moment for the Investment Round, where Member States and philanthropies are expected to announce funding for WHO. 

Member States will assess progress made over the past year, including a review of the 2024 Results Report – the final report measuring progress toward WHO’s Triple Billion targets under its Thirteenth General Programme of Work. 

The Health Assembly will consider approximately 75 items and sub-items and is expected to approve more than 40 resolutions/decisions, many of which are put forward by the Executive Board at its 156th session (EB156), where they have been previously discussed. 

The packed agenda covers a diverse range of topics in WHO’s Programme of Work, such as the health and care workforce, antimicrobial resistance, health emergencies, preparedness, polio, climate change and social connection as determinants of health, among other issues.  

On the morning of Friday, 23 May, the WHA President will present public health prizes and awards, recognizing exceptional contributions by individuals and organizations to the advancement of public health. 

It is also expected that the Director-General will announce two Director-General’s Awards for Global Health on the morning of Tuesday, 20 May. 

Forty-five official side events will take place at the Palais des Nations from Monday 19 May to Saturday 24 May (see the complete list).  A list of other events is available here.   

A high-level pledging event will be held on Tuesday 20 May, from 18:45 to 19:45 CEST in Room XVIII at the Palais des Nations. The event: Sustainable financing of WHO for impact in the new global health landscape, will serve as a platform for Member States and partners to announce pledges and commitments towards WHO’s Investment Round. More details and webcast.

A Ministerial Roundtable on data and sustainable financing will be held on Wednesday 21 May, from 13:00 to 14:20 CEST in Room XVIII at the Palais des Nations. This high-level roundtable will bring together ministers of health and finance, global partners, and technical leaders to identify scalable actions that strengthen country-led health data systems and sustainable financing strategies for universal health coverage and the health-related SDGs. More information: here.

Due to resource constraints, additional events will be limited. WHA78 will take place in a challenging financial environment. Several actions have been taken by the WHO in an effort to contain costs, including reducing speaking times when possible, in order to reduce evening sessions to a minimum, severely limiting hospitality, displays and exhibits and event costs, amongst other administrative cost-saving measures. 

Member States and partners are organizing events on the sidelines of the WHA. More information through the WHA Guide and the WHA78 page through the UN Foundation.

• Monday 19 May: Morning: Opening of the Assembly; including the presidential address and the address by Dr Tedros Adhanom Ghebreyesus, Director-General. Committee A begins deliberations on the Pandemic Agreement in the afternoon.
• Tuesday 20 May: Morning: Adoption of the Pandemic Agreement (expected), followed by the High-level Segment featuring statements from dignitaries and a Director-General’s keynote speech and the Director-General's Awards for Global Health. Afternoon, Committee A: Discussion on the Proposed Programme Budget 2026–2027, including discussion on the AC increase. Evening: high-level pledging event for the WHO Investment Round
• Wednesday 21 May: Lunch hour: Ministerial Roundtable on data and sustainable financing
• Friday 23 May: Morning: Presentation of the Public Health Prizes and Awards  

The agenda and the times might change. A daily journal will be published every morning on the WHA78 Documents page to provide more detailed information on the daily timings. 

The Health Assembly will take place after the Forty-second Meeting of the Programme, Budget and Administrative Committee of the Executive Board (PBAC42), which is being held from 14 to 16 May.

After the Assembly, the 157th Executive Board (EB157) meeting will take place on 28 and 29 May, with the appointment of the next Regional Director for the WHO African Region on the agenda. Related to this item, a special session of the AFRO Regional Committee will take place on Sunday 18 May to nominate a candidate for the post of Regional Director. The webcast of the EB157 public sessions and related documentation is here. 

As WHO’s highest decision-making body, the World Health Assembly sets out the Organization’s policy and approves its budget. The Health Assembly is attended by delegations from all WHO Member States.

• Seventy-eighth World Health Assembly
• Provisional agenda 
• Live webcast of WHA78 public sessions
  

As we make this transition to the new leadership team, I want to express my sincere appreciation for the remarkable contributions of those colleagues who will be leaving their executive management positions on 16 June 2025.

I am truly grateful to: 

Dr Michael J. Ryan, Deputy Director-General and Executive Director for Health Emergencies, Preparedness, and Response.  Mike planned to leave over two years ago but stayed on at my request, and I am very thankful for that. His steady presence has been instrumental during our toughest times, especially during the COVID-19 pandemic.  His dedication to emergency response has changed how we work, helping us face unprecedented challenges with compassion and effectiveness. I also appreciate his leadership during the prioritization process in these difficult times.

Dr Bruce Aylward, Assistant Director-General for UHC/Life Course for his key role in responding to public health emergencies like Ebola and COVID-19. He showed a unique talent for building partnerships through the ACT-A initiative, driving forward WHO’s transformation agenda, and leading the development of the Fourteenth General Programme of Work, 2025–2028. 

Dr Samira Asma, Assistant Director-General for Data, Analytics, and Delivery for Impact, for her strong commitment to improving the role of data, evidence, and measurable impact at the country level, and for establishing the WHO data hub.

Dr Catharina Cora Boehme, Assistant Director-General for External Relations and Governance, for her leadership in creating and driving the first-ever Investment Round aimed at sustainable financing for WHO and her earlier role as Chef de Cabinet.

Dr Li Ailan, Assistant Director-General for UHC/Healthier Populations, for her incredible leadership in WHO’s Healthier Populations initiative.  Her experience at both regional and country levels has been invaluable in ensuring our focus remains on prevention and addressing health issues that affect people's lives.

Dr Jérôme Salomon, Assistant Director-General, UHC/Communicable and Noncommunicable Diseases for his contribution in advancing the agenda on communicable diseases, noncommunicable diseases, mental health and neglected tropical diseases across silos to better integrate services and strengthen health systems.

As our colleagues move on to their next chapters, I want to thank them, once again, for their dedication to our mission and for their exceptional leadership and service.

The risk of famine in Gaza is increasing with the deliberate withholding of humanitarian aid, including food, in the ongoing blockade.

The entire 2.1 million population of Gaza is facing prolonged food shortages, with nearly half a million people in a catastrophic situation of hunger, acute malnutrition, starvation, illness and death. This is one of the world’s worst hunger crises, unfolding in real time.

The latest food security analysis was released today by the Integrated Food Security Phase Classification (IPC) partnership, of which WHO is a member.

“We do not need to wait for a declaration of famine in Gaza to know that people are already starving, sick and dying, while food and medicines are minutes away across the border,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “Today’s report shows that without immediate access to food and essential supplies, the situation will continue to deteriorate, causing more deaths and descent into famine.”

Famine has not yet been declared, but people are starving now. Three quarters of Gaza’s population are at “Emergency” or “Catastrophic” food deprivation, the worst two levels of IPC's five level scale of food insecurity and nutritional deprivation.

Since the aid blockade began on 2 March 2025, 57 children have reportedly died from the effects of malnutrition, according to the Ministry of Health. This number is likely an underestimate and is likely to increase.  If the situation persists, nearly 71 000 children under the age of five are expected to be acutely malnourished over the next eleven months, according to the IPC report.

People in Gaza are trapped in a dangerous cycle where malnutrition and disease fuel each other, turning everyday illness into a potential death sentence, particularly for children. Malnutrition weakens the bodies, making it harder to heal from injuries and fight off common communicable diseases like diarrhoea, pneumonia, and measles. In turn, these infections increase the body’s requirement for nutrition, while reducing nutrient intake and absorption, resulting in worsening malnutrition. With health care out of reach, vaccine coverage plummeting, access to clean water and sanitation severely limited, and increased child protection concerns, the risk of severe illness and death grows, especially for children suffering from severe acute malnutrition, who urgently need treatment to survive.

Pregnant and breastfeeding mothers are also at high risk of malnutrition, with nearly 17 000 expected to require treatment for acute malnutrition over the next eleven months, if the dire situation does not change. Malnourished mothers struggle to produce enough nutritious milk, putting their babies at risk, while the delivery of counselling services for mothers is heavily compromised. For infants under six months, breastmilk is their best protection against hunger and disease – especially where clean water is scarce, as it is in Gaza.

The long-term impact and damage from malnutrition can last a lifetime in the form of stunted growth, impaired cognitive development, and poor health. Without enough nutritious food, clean water, and access to health care, an entire generation will be permanently affected.

The plan recently announced by Israeli authorities to deliver food and other essential items across Gaza via proposed distribution sites is grossly inadequate to meet the immediate needs of over two million people. WHO echoes the UN’s call for the global humanitarian principles of humanity, impartiality, independence and neutrality to be upheld and respected and for unimpeded humanitarian access to be granted to provide aid based on people’s needs, wherever they may be. A well-established and proven humanitarian coordination system, led by the UN and its partners, is already in place and must be allowed to function fully to ensure that aid is delivered in a principled, timely, and equitable manner.

The aid blockade and shrinking humanitarian access continue to undermine WHO’s ability to support 16 outpatient and three inpatient malnutrition treatment centres with life-saving supplies, and to sustain the broader health system. The remaining supplies in WHO’s stocks inside Gaza are only enough to treat 500 children with acute malnutrition – a fraction of the urgent need – while essential medicines and supplies to treat diseases and trauma injuries are already running out and cannot be replenished due to the blockade.

People are dying while WHO and partners’ life-saving medical supplies sit just outside Gaza – ready for deployment, with safeguards in place to ensure the aid reaches those who need it most in line with humanitarian principles. WHO calls for the protection of health care and for an immediate end to the aid blockade, which is starving people, obstructing their right to health, and robbing them of dignity and hope. WHO calls for the release of all hostages, and for a ceasefire, which leads to lasting peace. 

The World Health Organization (WHO) Results Report 2024, shows progress on global health goals, even in times of growing financial uncertainties.

The report, released ahead of the Seventy-eight World Health Assembly (19–27 May 2025), presents a mid-term assessment of WHO’s performance in implementing the Programme budget 2024–2025, providing a snapshot of progress towards the strategic priorities of the Thirteenth General Programme of Work, 2019–2025.

The report highlights WHO’s work in over 150 countries, territories and provides an update on the implementation of the Thirteenth General Programme of Work, showcasing both the achievements so far and challenges ahead.

“This report shows how, with WHO’s support, many countries are making progress on a huge range of health indicators, helping their populations to live healthier lives, giving them greater access to essential health services, and keeping them safer against health emergencies,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “In a world of multiple overlapping challenges and constrained resources for global health, these results demonstrate why the world needs a strong and sustainably-financed WHO, delivering the high-quality, trusted support on which countries and their people rely.”

The report shows significant progress on coverage with essential health services, protection from health emergencies, and enjoyment of healthier lives. Still, the progress is insufficient to reach the health-related Sustainable Development Goals by 2030.

On the first billion – 1 billion more people benefitting from universal health coverage – an estimated 431 million more people, close to half of the goal, are estimated to be covered with essential health services without catastrophic health spending. This progress is largely driven by improvements in the healthcare workforce, increased access to contraception and expanded HIV antiretroviral therapy. However, people continue to face financial hardships and challenges in immunization programmes persist.

Regarding the second billion – 1 billion more people better protected from health emergencies – an estimated 637 million more people are better protected through stronger preparedness, surveillance, workforce capacity, and equitable access to tools and services, supported by reforms such as the amendments to the International Health Regulations. Yet financial constraints threaten pandemic response efforts. In the face of the H5N1 avian flu outbreak, there is a continued need for pandemic preparedness. After more than three years of negotiations, WHO member states have drafted a pandemic agreement that will be up for consideration at the upcoming World Health Assembly. The draft proposal includes measures for an increased research infrastructure, emergency global health workforces and other key mechanisms to prevent and respond to pandemic threats.

For the third billion – 1 billion more people enjoying better health and well-being – the report shows that 1.4 billion more people are living with better health and well-being, surpassing the initial goal. This is due to reduced tobacco use, improved air quality, clean household fuels, and access to water, sanitation and hygiene (WASH). Key challenges lie in addressing increased obesity and alcohol consumption.

However, reaching the goals faces growing challenges. Pause in foreign aid and reduction of health budgets further strain already fragile health systems, especially in communities with the greatest health needs. Financial constraints threaten pandemic response efforts. Reduced funding will also undermine hard-won progress.

WHO has taken concrete steps to become more efficient and effective, including by improving operational efficiency and transparency through digital innovation, enhanced support services, and stronger risk and security systems. In 2024, WHO strengthened its support for generating, accessing and using data paving the way for more evidence-based programming and timelier on the ground impact.

Seven countries eliminated a neglected tropical disease in 2024, reaching 54 countries that have eliminated at least one neglected tropical disease. Guinea worm disease is now closer than ever to eradication.

WHO assigned 481 international nonproprietary names for medicines and 185 countries accessed the WHO database of medical devices nomenclature.

Seventy million more people had access to mental health services by the end of 2024 and at least one million people living with a mental health condition received treatment.

An emergency polio campaign in the Gaza Strip vaccinated more than half a million children.

With support from the African Centers for Disease Control and Prevention, WHO distributed 259 000 mpox tests in 32 countries. Globally, 6 million mpox vaccine doses were pledged.

WHO coordinated responses to 51 graded emergencies in 89 countries and territories. WHO’s emergency medical teams performed more than 37 000 surgeries and supported infection prevention and control, WASH, trauma care, and mental health support.

WHO trained over 15 000 health providers and policy-makers across more than 160 Member States on addressing the health needs of refugees and migrants.

WHO collaboration with UNICEF and other UN agencies has resulted in multiyear funding programmes in 15 high-burden countries, reaching 9.3 million children and saving an estimated 1 million lives.

Increasing efficiency, the global digital health certification network supported by WHO has now enabled about 2 billion people to carry digital health records.

WHO recognizes the sustained commitment of Member States and will work with new and existing donors and partners to secure additional funding. Securing predictable, sustainable and resilient financing is the key objective of the Investment Round, which has mobilized over US$ 1.7 billion in pledges from 71 contributors, covering 53% of WHO’s voluntary funding needs.

The Results Report is crucial to WHO’s accountability to Member States. This report ensures that funding is used to deliver impact, results are regularly measured, and future needs are correctly identified, based upon lessons-learned.

The global nursing workforce has grown from 27.9 million in 2018 to 29.8 million in 2023, but wide disparities in the availability of nurses remain across regions and countries, according to the State of the World’s Nursing 2025 report, published by the World Health Organization (WHO), International Council of Nurses (ICN) and partners. Inequities in the global nursing workforce leave many of the world’s population without access to essential health services, which could threaten progress towards universal health coverage (UHC), global health security and the health-related development goals. 

The new report released on International Nurses Day provides a comprehensive and up-to-date analysis of the nursing workforce at global, regional and country levels. Consolidating information from WHO’s 194 Member States, the evidence indicates global progress in reducing the nursing workforce shortage from 6.2 million in 2020 to 5.8 million in 2023, with a projection to decline to 4.1 million by 2030. But, the overall progress still masks deep regional disparities: approximately 78% of the world’s nurses are concentrated in countries representing just 49% of the global population.  

Low- and middle-income countries are facing challenges in graduating, employing and retaining nurses in the health system and will need to raise domestic investments to create and sustain jobs. In parallel, high-income countries need to be prepared to manage high levels of retiring nurses and review their reliance on foreign-trained nurses, strengthening bilateral agreements with the countries they recruit from.   

"This report contains encouraging news, for which we congratulate the countries that are making progress,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “However, we cannot ignore the inequalities that mark the global nursing landscape. On International Nurses Day, I urge countries and partners to use this report as a signpost, showing us where we’ve come from, where we are now, and where we need to go – as rapidly as possible.”

The State of the World’s Nursing 2025 (SoWN) report, based on data reported by 194 countries through the National Health Workforce Accounts, shows a 33% increase in the number of countries reporting data since the last edition in 2020. It includes detailed country profiles now available for public access online.

The report reveals complex disparities between and among countries, regions and socio-economic contexts. The data and evidence are intended to support country-led dialogue to contextualize the findings into policies and actions.

“We welcome the SoWN 2025 report as an important milestone for monitoring progress on strengthening and supporting the nursing workforce towards global health goals,” said Pam Cipriano, President, International Council of Nurses. “The report clearly exposes the inequalities that are holding back the nursing profession and acting as a barrier to achieving universal health coverage (UHC). Delivering on UHC is dependent on truly recognizing the value of nurses and on harnessing the power and influence of nurses to act as catalysts of positive change in our health systems.”

Gender and equity remain central concerns in the nursing workforce. Women continue to dominate the profession, making up 85% of the global nursing workforce.

Findings suggest that 1 in 7 nurses worldwide – and 23% in high-income countries – are foreign-born, highlighting reliance on international migration. In contrast, the proportion is significantly lower in upper middle-income countries (8%), lower middle-income countries (1%), and low-income countries (3%).

Low-income countries are increasing nurse graduate numbers at a faster pace than high-income countries. In many countries, hard-earned gains in the graduation rate of nurses are not resulting in improved densities due to the faster pace of population growth and lower employment opportunities.  To address this, countries should create jobs to ensure graduates are hired and integrated into the health system and improve working conditions.

Age demographics and retirement trends reveal a mixed picture. The global nursing workforce is relatively young: 33% of nurses are aged under 35 years, compared with 19% who are expected to retire in the next 10 years. However, in 20 countries – mostly high-income – retirements are expected to outpace new entrants, raising concerns about nurse shortfalls, and having fewer experienced nurses to mentor early career nurses.

Around two thirds (62%) of countries reported the existence of advanced practice nursing roles – marking significant progress since 2020 (where only 53% reported advanced practice nursing roles).  These types of nurses have been shown to expand access to and quality of care in many different settings.  

The report also highlights improvements in nursing leadership: 82% of countries reported having a senior government nursing official to manage the nursing workforce. However, leadership development opportunities remain uneven. While 66% of countries report having such initiatives in place, only 25% of low-income countries offer structured leadership development.

Mental health and workforce well-being remain areas of concern. Only 42% of responding countries have provisions for nurses’ mental health support, despite increased workloads and trauma experienced during and since the COVID-19 pandemic. Addressing this is essential to retain skilled professionals and ensure quality of care.

The report introduces forward-looking policy priorities, calling on countries to:

• expand and equitably distribute nursing jobs, especially in underserved regions;
• strengthen domestic education systems and align qualifications with defined roles;
• improve working conditions, pay equity, and mental well-being support;
• further develop nursing regulation and advanced practice nursing roles;
• promote gender equity and protect nurses working in fragile, conflict-affected settings;
• harness digital technologies and prepare nurses for climate-responsive care; and
• advance nursing leadership and ensure leadership development opportunities are equitable.

The evidence in the report provides an impetus for continued alignment to the policy priorities in the WHO Global Strategic Directions for Nursing and Midwifery 2021–2025, and the actions recommended in the resolution submitted to the 78th World Health Assembly:  Accelerating action on the health and care workforce by 2030.

Note to editors:

The State of the World’s Nursing 2025 report presents the most contemporary evidence on the global nursing workforce, including education, employment, migration, regulation, working conditions, leadership and more. The report includes updated indicators and robust estimates on global and regional-level nursing stock, shortage, and projections to 2030. Online county profiles provide national level data in a downloadable (PDF) format.  

The World Health Organization (WHO) and Medicines Patent Pool (MPP) have today announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor (SDB). This agreement will contribute to advancing equitable access to vital diagnostic tools through local production, expanding manufacturing capacity in the African Region.

The new RDT technology is especially useful for low- and middle-income countries (LMICs), as it is easy to use in health facilities without requiring additional equipment. Tests are highly sensitive and can generate results within 20 minutes. Codix Bio will initially focus on producing RDTs for HIV, but the technology can also be used for manufacturing tests for malaria and syphilis, among others. It can also be quickly adapted to other diseases, which will prove valuable during health emergencies and pandemics, contributing to improvements in health security and equity.

"Sublicensing SDB’s RDT technology marks a major milestone in strengthening manufacturing capabilities in regions where they are needed most,” said Dr Yukiko Nakatani, WHO Assistant Director-General, Access to Medicines and Health Products. “It can help advance global commitments made at the 2023 World Health Assembly to promote equitable access to diagnostics as a cornerstone of universal health coverage and pandemic preparedness.”

“We are delighted to have signed this first sublicense agreement for RDTs with Codix Bio. Today marks a major step forward in diversifying diagnostic production and ensuring access where it is needed most,” said Charles Gore, Executive Director of the Medicines Patent Pool. “It shows how voluntary licensing and coordinated technology transfer can empower manufacturers in LMICs, ultimately helping reshape global supply chains to become more equitable and resilient.”

This agreement is the first to come out of a non-exclusive, transparent license between SDB and MPP, which was agreed in December 2023 under the auspices of the WHO COVID-19 Technology Access Pool (C-TAP) initiative. C-TAP has since evolved as HTAP – the Health Technology Access Programme, with the goal of reducing the access gap in underserved regions and countries by empowering capable local producers of health products (tests, vaccines, treatments and medical devices) through sublicensing, technology and know-how transfer.

“The announcement of this sublicensing agreement with Codix Bio marks an important milestone in our partnership with WHO and MPP. By coupling the technology transfer with coordinated support, this initiative not only helps Codix Bio respond to health priorities in Nigeria and the region – it also demonstrates a collaborative model for building sustainable and self-reliant local manufacturing capacity,” said Hyo-Keun Lee, Vice Chairman of SD Biosensor, Inc. “We are proud that our highly adaptable and reliable rapid diagnostic testing technology will contribute to strengthening regional manufacturing ecosystems and expanding equitable access to diagnostics.”  

After the WHO and MPP open call was announced for applications for LMIC-based manufacturers, Codix Bio was selected as the first sublicensee. “This landmark agreement is a defining moment in our journey of health-tech innovation and a breakthrough for local healthcare manufacturing in Africa. Being selected as the first sublicensee under this global initiative underscores our commitment to contribute meaningfully to pandemic preparedness and regional health security,” said Sammy Ogunjimi, Group Managing Director/CEO, Codix Group. “With support from WHO and MPP, we are committed to producing high-quality, rapid diagnostic tests that can transform access to timely diagnosis, not just in Nigeria, but across the continent.”

HTAP will coordinate support from across WHO and its partners, covering areas such as workforce development, regulatory compliance and product uptake. It is also continuing with evaluations for a potential second sublicensee for this technology transfer.

Most LMICs rely on importing health diagnostics. Following fragility and heavy dependence on imported health product supplies during the COVID-19 pandemic and important lessons learnt for regional health security, there is growing momentum for improving local production and supply resilience, including by institutions such as the Africa Centres for Disease Control and Prevention (Africa CDC), the Global Fund and Unitaid.

"Africa CDC welcomes this partnership as a concrete example of what regional health security can look like. Building diagnostic manufacturing capacity within the continent improves pandemic response and helps build African health sovereignty. We are pleased to see Africa CDC’s strategic direction reflected in this initiative, and we stand ready to support its implementation through coordination and technical assistance,” said Dr Abebe Bayih, lead of the Platform for Harmonized African Health Manufacturing (PHAH).
 

About Medicines Patent Pool (MPP)
The Medicines Patent Pool (MPP) is a United Nations-backed public health organization working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organizations, industry, patient groups, and other stakeholders to prioritize and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. medicinespatentpool.org

About WHO
Dedicated to the well-being of all people and guided by science, the World Health Organization leads and champions global efforts to give everyone, everywhere an equal chance at a safe and healthy life. We are the UN agency for health that connects nations, partners and people on the front lines in 150+ locations – leading the world’s response to health emergencies, preventing disease, addressing the root causes of health issues and expanding access to medicines and health care. Our mission is to promote health, keep the world safe and serve the vulnerable. www.who.int

As the 8th UN Global Road Safety Week kicks off around the world under the theme “Make walking and cycling safe,” the World Health Organization (WHO) has launched a new toolkit to help governments promote active mobility – by making it safer.

Each year, nearly 1.2 million people lose their lives on the roads, more than a quarter of them while walking or cycling. Yet, only 0.2% of the roads worldwide are equipped with cycle lanes, and far too many communities lack basics like sidewalks or safe pedestrian crossings.

“Walking and cycling improve health and make cities more sustainable. Every step and every ride help to cut congestion, air pollution and disease,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “But we must make walking and cycling safe, so more people choose these healthier, greener options.”

Despite their benefits, fewer than one-third of countries have national policies to promote walking and cycling. WHO’s new toolkit aims to fill that gap with practical, evidence-based guidance for policymakers, urban planners, health advocates and civil society. The toolkit calls for bold action including:

• integrating walking and cycling into transport, health, environmental and education policies;
• building safe infrastructure like sidewalks, crossings and protected cycle lanes;
• setting and enforcing safer speed limits aligned with global best practices;
• promoting safe road use through public awareness and behaviour change campaigns; and
• using financial incentives to encourage active mobility.

While global pedestrian deaths dropped slightly and cyclist deaths plateaued between 2011 and 2021, regional trends show growing danger:

• In the WHO South-East Asia Region, pedestrian deaths rose by 42%.
• In the European Region, cyclist deaths surged by 50%.
• In the Western Pacific Region, cyclist deaths soared by 88%.

This week, WHO joins hundreds of organizations and governments worldwide to demand urgent action on road safety. The Global Alliance of NGOs for Road Safety is mobilizing over 400 member organizations in 100 countries to support the campaign.

“It is urgent to make, what should be our most natural means of transport, safer. This is paramount for road safety, but also health, equity and climate,” said Etienne Krug, Director of the WHO Department for the Social Determinants of Health. “We’re calling on all sectors – transport, health, education and beyond – to make walking and cycling safe and accessible for everyone.”

The Global Outbreak Alert and Response Network (GOARN), an initiative coordinated by the World Health Organization (WHO), marks its 25th anniversary today. Since its inception in April 2000, the network has been at the forefront of the global fight against health emergencies. By leveraging the expertise of global partners – facilitating alerts, deploying rapid support capacities, and strengthening capacities – it has significantly enhanced country-level operations and strengthened regional development, playing a critical role in health preparedness and response.

“GOARN is a vital part of the global health architecture,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Through the network, countries get the expert support they need to respond to health emergencies, and to enhance their own capacities for preparedness and response. This means faster, more effective responses and more lives saved.”

GOARN was created in response to the need for better coordination during global health emergencies. While many partner organizations were sending teams to assist during emergencies, there was a lack of coordination which hindered the overall effectiveness of these responses. It was also clear that no single institution could address all components of a response alone. GOARN was thus born following an international meeting organized by WHO in Geneva on 26–28 April 2000. Some 121 representatives from 67 partner institutions discussed the growing challenge of epidemic-prone and emerging diseases, and the urgent need to build a global network based on existing partnerships to address these threats.

In October 2000, GOARN played a key role in responding to the major Ebola outbreak in Gulu, Uganda – marking a significant milestone in what would evolve into a quarter-century of pivotal global health responses.

“As one of the first responders deployed during the Ebola outbreak in Uganda 25 years ago, I witnessed firsthand the evolution of our response efforts and GOARN’s role,” said Dr Mike Ryan, Executive Director of WHO’s Health Emergencies Programme and Deputy Director-General of WHO.  “When I returned to Uganda earlier this year for another Ebola response, I was immensely proud to see how strong the national capacities have become, led by the Ministry of Health with the support of WHO and GOARN partners. GOARN is an example of how multilateralism works to save lives. To this day, I wear the orange GOARN lanyard alongside my blue WHO one to show my respect for and pride in this network.”

GOARN leverages the expertise of its partner institutions to address global health challenges. Operating as a unified international community, the network has responded swiftly and effectively to public health threats by deploying technical experts to ensure the right expertise is in the right place at the right time. GOARN's goal is to strengthen countries' capacities and help build strong, resilient systems for response to emergencies.

GOARN ensures that the experts are well-trained and equipped with the right skills before they’re deployed where they are needed most, fostering seamless collaboration for swift, coordinated, and impactful responses.

GOARN has now grown into a network of over 310 institutions, including national public health agencies, nongovernmental organizations, UN agencies, academic, and other technical organizations. GOARN has responded to over 175 public health emergencies in 114 countries, deploying more than 3645 international responders who integrate within national responses, collaborating with thousands of national professionals to strengthen and enhance local efforts. The network has tackled major global public health events, including outbreaks of SARS, Ebola virus disease, Marburg virus disease, COVID-19, mpox, cholera, yellow fever, disasters such as floods and earthquakes, and war. GOARN has deployed expertise in epidemiology, disease surveillance, case management, clinical care, infection prevention and control, risk communication and community engagement, and others. These efforts have also delivered hands-on training to hundreds of national teams, bolstering their immediate response capacity and long-term resilience.

"Looking back over the past 25 years, it’s remarkable to see how GOARN has evolved from a visionary concept to an indispensable network in the global health emergency landscape,” said Ray R. Arthur, PhD, Director, Global Disease Detection Operations Center, CDC (retired) and Former Chair of the GOARN Steering Committee. “As an early participant in establishing the network and as former chair of the Steering Committee, I witnessed firsthand the commitment and collaboration that drove the network’s success. GOARN has not only facilitated rapid response to public health emergencies but has also been instrumental in strengthening global health, ensuring that countries are better prepared for the challenges of tomorrow. It’s an honour to see the network continue to grow and play such a vital role in protecting public health worldwide."

Today, GOARN is a vital pillar in the Global Health Emergency Corps ensuring a well-coordinated health emergency workforce, centered in countries and connected regionally and globally. The 25-year milestone marks a significant evolution of GOARN’s role in preparedness and response. Rather than deploying large numbers of international professionals across every field, GOARN now brings in only the necessary expertise to address critical gaps on the ground. Paired with the focus on capacity strengthening and training initiates, GOARN has demonstrated the effectiveness of its mandate and efforts empowering countries to manage emergencies themselves.

GOARN calls on all Member States, partners and the global community to continue working together to build a global health emergency architecture that is resilient, equitable, and capable of addressing future health challenges.
 

Dr Mohannad Al-Nsour, Executive Director, Eastern Mediterranean Public Health Network (EMPHNET), current Chair of the GOARN Steering Committee:
“As the world faces the growing threats of epidemics, conflict, and humanitarian crises, GOARN’s role has never been more vital. The network is being called to respond in increasingly complex environments – where conflict is more widespread, and public health emergencies unfold alongside deep humanitarian challenges. GOARN must continue to evolve, expanding its reach and strengthening collaboration to meet these urgent needs.”

Daniela Garone, Infectious Diseases Specialist and International Medical Coordinator, Médecins Sans Frontières, current Co-Deputy Chairs of the GOARN Steering Committee and Dr Edmund Newman, Director, UK Public Health Rapid Support Team (UK-PHRST):
"Reflecting on GOARN’s 25 years of advancing global health emergency preparedness and response, we are proud to be active partners of a network that has been instrumental in saving lives and strengthening health response systems around the world. From its humble beginnings to its current role as a vital pillar in global health response, GOARN has demonstrated the power of collaboration and expertise in tackling public health emergencies. As we look to the future, we remain committed to supporting countries in building resilient public health systems and ensuring that our collective efforts continue to evolve in response to the growing challenges of global health. Together, we will continue to foster stronger partnerships and be ready for whatever comes next."

Myriam Henkens MD, MPH, Senior Health Adviser, Médecins Sans Frontières, former member of GOARN Steering Committee:
“For 25 years, GOARN has been a cornerstone in the global response to health emergencies. As a proud participant, MSF has been working alongside GOARN to strengthen health systems and ensure a more effective global response to the challenges of tomorrow. The collaborative spirit and shared expertise across the network have made a real difference in the field, and I’m proud to have been part of this journey.”

Gail Carson, Director of Network Development at ISARIC Pandemic Sciences Institute, University of Oxford and former Chair of the GOARN Steering Committee (2022–2024):
“Serving as Chair of the GOARN Steering Committee from 2022 to 2024 was one of the greatest honours of my career. But my connection to this network goes back much further—to GOARN’s first response to Ebola in Uganda. Over the past 25 years, I’ve seen firsthand how this global community of experts supports countries in times of crisis, delivering trusted, timely, and lifesaving technical assistance. Today, GOARN continues to evolve to meet new and complex challenges. What hasn’t changed is its core strength: GOARN remains the partner you can count on when a health emergency hits.”

John S Mackenzie, Emeritus Professor and former Chair of the GOARN Steering Committee:
“GOARN was born from a visionary belief that global outbreak response could be stronger through coordinated action. I was proud to serve on its first Steering Committee, and those 14 years remain among the most fulfilling of my career. GOARN continues to grow as a powerful force in global public health – driven by collaboration, expertise, and an enduring spirit of service.”

Pat Drury, former GOARN Manager:
“GOARN has been more than just a professional milestone—it has been a journey of saving lives and making a real difference in the face of some of the world’s most challenging outbreaks, from Ebola, and SARS to COVID-19. The network’s strength is its ability to connect people, and institutions, knowledge and expertise in real time, turning alerts into rapid responses. As the challenges have grown, so have the stakes. In an increasingly polarised world, GOARN’s role in mobilizing science, and fostering trust has never been more vital. Congratulations on 25 years of extraordinary impact, and thank you to the countless individuals who make this mission possible.”